Tracy Valorie, MBA

Ms. Tracy Valorie is a strategic business consultant and the owner of TMV Associates LLC . Since July 2019 she has been an strategic advisor to Atia Vision and Myra Vision, and has provided consulting services several other start up companies. Ms. Valorie has more than30 years of experience in the pharmaceutical and biotech industry. Ms. Valorie served as the senior vice president, general manager of the U.S. pharmaceutical and surgical businesses at Bausch + Lomb from July 2012 to May 2019. Prior to joining B+L in 2012, Ms. Valorie served as commercial lead of ophthalmology at Pfizer Inc. (NYSE: PFE) where she had global responsibility for the ophthalmology brands as well as responsibility for commercial development of the mid-stage portfolio and long-range strategic planning. Ms. Valorie currently sits on the boards of PolyActiva Pty Ltd. since September 2020, Samsara Vision since January 2021, and Visus Therapeutics since August 2021. Ms Valorie has recently been appointed to the board of the Glaucoma Research Foundation (GRF). In addition, Ms. Valorie has previously held board membership seats at Ophthalmic World Leaders (OWL) from the Fall of 2014 to the Fall of 2018, The Glaucoma Foundation from November 2009-Sept 2011 and the ARVO Foundation for Eye Research over the same time period. Ms. Valorie holds a Masters in Business Administration from Rensselaer Polytechnic Institute and a Bachelor of Science in Molecular Biology from the University of Connecticut at Storrs, CT.